Lack of association between COMT gene and deficit/nondeficit schizophrenia

Behavioral and Brain Functions

Volumn 2, Issue , 2006, Pages 1-10

  Wonodi, Ikwunga ^a   Mitchell, Braxton D ^b   Stine, O Colin ^b   Hong, L Elliot ^a   Elliott, Amie ^a   Kirkpatrick, Brian ^a   Carpenter, William T ^a   Thaker, Gunvant K ^a   Buchanan, Robert W ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46949083277     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-2-1     Document Type: Article

References (29)

1. Adler LE, Freedman R, Ross RG, Olincy A, Waldo MC: Elementary phenotypes in the neurobiological and genetic study of schizophrenia. Biol Psychiatry 1999, 46:8-18.
2. Harrison PJ, Weinberger DR: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2004.
3. Tsuang MT: Defining alternative phenotypes for genetic studies: what can we learn from studies of schizophrenia? Am J Med Genet 2001, 105:8-10.
4. Carpenter WT Jr., Heinrichs DW, Wagman AM: Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988, 145:578-583.
5. Buchanan RW, Carpenter WT: Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Dis 1994, 182:193-204.
6. Carpenter WT Jr., Arango C, Buchanan RW, Kirkpatrick B: Deficit psychopathology and a paradigm shift in schizophrenia research. Biol Psychiatry 1999, 46:352-360.
7. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr.: A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001, 58:165-171.
8. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE: Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001, 50:825-844.
9. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF: Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996, 67:468-472.
10. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
11. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR: Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003, 60:889-896.
12. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A, Fananas L: New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 2004, 161:1110-1112.
13. Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940-945.
14. Karayiorgou M, Gogos JA: The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 2004, 132:95-104.
15. Kastner A, Anglade P, Bounaix C, Damier P, Javoy-Agid F, Bromet N, Agid Y, Hirsch EC: Immunohistochemical study of catechol-Omethyltransferase in the human mesostriatal system. Neuroscience 1994, 62:449-457.
16. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM, Herman MM, Weinberger DR, Kleinman JE: Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003, 28:1521-1530.
17. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ: Catechol-omethyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 2004, 24:5331-5335.
18. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI: Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 1998, 18:2697-2708.
19. Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT: Attentional impairments in deficit and nondeficit forms of schizophrenia. Am J Psychiatry 1997, 154:363-370.
20. Wonodi I, C. S, Mitchell BD, Buchanan R, Thaker G: Association between Val 108/158 Met polymorphisms of the COMT gene and schizophrenia. Am J Med Genet 2003, 120B:47-50.
21. Carpenter WT Jr., Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS: Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 2000, 57:533-538.
22. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders Arlington, American Psychiatric Publishing, Inc; 1997.
23. Pfohl B, Blum N, Zimmerman M: Structured Interview for DSM-IV Personality 1997.
24. Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 1977, 34:1229-1235.
25. Glatt SJ, Faraone SV, Tsuang MT: Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and familybased studies. Am J Psychiatry 2003, 160:469-476.
26. Williams HJ, Glaser B, Williams NM, Norton N, Zammit S, Macgregor S, Kirov GK, Owen MJ, O'Donovan MC: No Association Between Schizophrenia and Polymorphisms in COMT in Two Large Samples. Am J Psychiatry 2005, 162:1736-1738.
27. Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, Feng GY, St Clair D, He L: Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a largescale association study plus meta-analysis. Biol Psychiatry 2005, 57:139-144.
28. Dauvilliers Y, Neidhart E, Lecendreux M, Billiard M, Tafti M: MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry 2001, 6:367-372.
29. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV: Familybased and case-control association studies of catechol-Omethyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet 2003, 118:103-109.